Table 1.
Patient characteristics
| Characteristics | Overall (n = 491) |
Pre-menopausal (n = 150) |
Post-menopausal (n = 341) |
P Value |
|---|---|---|---|---|
| Age, mean (SD) | 59.8 (11.6) | 48 (5.5) | 64.9 (9.7) | < 0.0001 |
| Body mass index (BMI) | 0.016 | |||
| Normal weight | 249 (50.7) | 90 (60.0) | 159 (46.6) | |
| Overweight | 145 (29.5) | 39 (26.0) | 106 (31.1) | |
| Obese | 97 (19.8) | 21 (14.0) | 76 (22.3) | |
| Metabolic syndrome present | 84 (17.1) | 10 (6.7) | 74 (21.7) | < 0.001 |
| ILC grade a | 0.315 | |||
| 1 | 145 (30.1) | 51 (34.9) | 94 (28.1) | |
| 2 | 316 (65.7) | 89 (61.0) | 227 (67.8) | |
| 3 | 20 (4.2) | 6 (4.1) | 14 (4.2) | |
| Hormone receptor subtype b | < 0.001 | |||
| ER + /PR + | 373 (79.7) | 131 (90.3) | 242 (74.9) | |
| ER + /PR- | 95 (20.3) | 14 (9.7) | 81 (25.1) | |
| ILC stage c | 0.059 | |||
| I | 315 (65.1) | 87 (58.4) | 228 (68.1) | |
| II | 105 (21.7) | 42 (28.2) | 63 (18.8) | |
| III | 64 (13.2) | 20 (13.4) | 43 (13.1) |
Data are expressed as n (%) unless otherwise specified. Total n = 491 unless otherwise specified. ILC, invasive lobular carcinoma; ER, estrogen receptor; PR, progesterone receptor
aData available for 481
bData available for 468
cData available for 484